NCT00501410 - FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 23, 2007

Primary Completion Date

March 3, 2017

Study Completion Date

March 3, 2017

Conditions

Colorectal Cancer

Interventions

DRUG

5-FU

2400 mg/m\^2 by vein over 46 Hours On Days 1 \& 2.

DRUG

Cetuximab

Initial Dose = 400 mg/m\^2 by vein, then 250 mg/m\^2 Weekly On Days 1 \& 8

DRUG

Dasatinib

Starting dose level: 100 mg by mouth daily on days 1-14.

DRUG

Leucovorin

400 mg/m\^2 by vein on day 1.

DRUG

Oxaliplatin

85 mg/m\^2 by vein on day 1.

Trial Locations (1)

University of Texas MD Anderson Cancer Center, Houston